BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 11987835)

  • 1. [Krakow Program for Secondary Prevention of Ischaemic Heart Disease. Part II. Secondary prevention of ischaemic heart disease during hospitalization].
    Kawecka-Jaszcz K; Jankowski P; Pajak A; Dubiel J; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2001; 58(11):956-63. PubMed ID: 11987835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Krakow Program for Secondary Prevention of Ischaemic Heart Disease. Part III. Secondary prevention of ischaemic heart disease after discharge].
    Kawecka-Jaszcz K; Jankowski P; Pajak A; Dubiel J; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2001; 58(11):964-8. PubMed ID: 11987836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cracovian program for secondary prevention of ischemic heart disease. Secondary prevention of ischemic heart disease during hospitalization in 1996-97 and 1998-99].
    Pajak A; Kawecka-Jaszcz K; Jankowski P; Bilo G; Dubiel JS; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2003; 60(3):136-41. PubMed ID: 14575013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. The quality of care in the field of secondary prevention of ischaemic heart disease depends on where patients are treated in the postdischarge period].
    Jankowski P; Kawecka-Jaszcz K; Pajak A
    Przegl Lek; 2001; 58 Suppl 6():21-5. PubMed ID: 11873737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Krakow Program for Secondary Prevention of Ischaemic Heart Disease. Part I. Genesis and objectives].
    Kawecka-Jaszcz K; Pajak A; Jankowski P
    Przegl Lek; 2001; 58(11):953-5. PubMed ID: 11987834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary prevention of coronary artery disease in hospital practice over the decade 1996-2006. Results of the Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of the EUROASPIRE II and EUROASPIRE III surveys.
    Jankowski P; Kawecka-Jaszcz K; Pajak A; Surowiec S; Wolfshaut R; Loster M; Badacz L; Dubiel JS; Grodecki J; Grodzicki T; Maciejewicz J; Mirek-Bryniarska E; Piotrowski W; Smielak-Korombel W; Tracz W
    Kardiol Pol; 2009 Aug; 67(8A):970-7. PubMed ID: 19784901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in secondary prevention of coronary artery disease in the post-discharge period over the decade 1997-2007. Results of the Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of the EUROASPIRE II and III surveys.
    Pajak A; Jankowski P; Kawecka-Jaszcz K; Surowiec S; Wolfshaut R; Loster M; Batko K; Badacz L; Dubiel JS; Grodecki J; Grodzicki T; Maciejewicz J; Mirek-Bryniarska E; Piotrowski W; Smielak-Korombel W; Tracz W
    Kardiol Pol; 2009 Dec; 67(12):1353-9. PubMed ID: 20054766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Instruction of patients and a delay of treatment in myocardial infarction and unstable angina in the Krakow Program of Secondary Prevention of Ischaemic Heart Disease (IHD)].
    Pajak A; Jankowski P; Dojka E; Kawecka-Jaszcz K
    Przegl Lek; 2001; 58(10):903-7. PubMed ID: 11957816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cracovian program for secondary prevention of ischemic heart disease. Secondary prevention of ischemic heart disease after discharge in 1997-98 and 1999-2000].
    Jankowski P; Kawecka-Jaszcz K; Pajak A; Bilo G; Dubiel JS; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2003; 60(3):142-6. PubMed ID: 14575014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current standard of care in patients affected by coronary heart disease in Italy: the MC'95 study.
    Magnani B; Dal Palù C; Zanchetti A;
    Ital Heart J; 2002 Feb; 3(2):86-95. PubMed ID: 11926017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme.
    EUROASPIRE II Study Group
    Eur Heart J; 2001 Apr; 22(7):554-72. PubMed ID: 11259143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
    Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [EUROASPIRE: survey conducted by the European Society of Cardiology on secondary prevention of coronary disease. Hungarian results].
    Ostör E; Jánosi A; Belatiny KA; Borbás S; Bradak A; Podmaniczky M
    Orv Hetil; 1999 Jan; 140(5):243-8. PubMed ID: 10064978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
    Hague W; Forder P; Simes J; Hunt D; Tonkin A;
    Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary prevention of coronary artery disease in contemporary clinical practice.
    Jankowski P; Czarnecka D; Wolfshaut-Wolak R; Łysek R; Łukaszewska A; Bogacki P; Grodecki J; Mirek-Bryniarska E; Nessler J; Podolec P; Kawecka-Jaszcz K; Pająk A
    Cardiol J; 2015; 22(2):219-26. PubMed ID: 25299500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute Coronary Syndrome patients in New Zealand receive less invasive management when admitted to hospitals without invasive facilities.
    Ellis C; Devlin G; Matsis P; Elliott J; Williams M; Gamble G; Mann S; French J; White H;
    N Z Med J; 2004 Jul; 117(1197):U954. PubMed ID: 15326507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cracovian program for secondary prevention of ischemic heart disease. Methods of intervention].
    Kawecka-Jaszcz K; Pajak A; Jankowski P
    Przegl Lek; 2003; 60(3):133-5. PubMed ID: 14575012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Secondary prevention of ischemic heart disease in diabetics in clinical practice].
    Pajak A; Jankowski P; Wolfshaut R; Kawecka-Jaszcz K
    Pol Arch Med Wewn; 2004 Oct; 112(4):1189-96. PubMed ID: 15773431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.